Moses Robert Kamya

Moses Robert Kamya's AcademicInfluence.com Rankings

Moses Robert Kamya

Philosophy

#8735

World Rank

#12170

Historical Rank

Logic

#5758

World Rank

#7185

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Moses Robert Kamya's Degrees

Bachelors Medicine Makerere University
Masters Internal Medicine Makerere University
PhD Medicine Makerere University

Why Is Moses Robert Kamya Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Moses Robert Kamya's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. (2008) (282)
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. (2010) (277)
Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy (2007) (237)
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. (2007) (192)
Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts. (2012) (186)
Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. (2001) (174)
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. (2016) (170)
Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities (2015) (169)
Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda (2014) (166)
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial (2007) (161)
Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. (2006) (161)
Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. (2015) (158)
Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. (2008) (154)
Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: implications for malaria control. (2015) (152)
HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa. (2019) (151)
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda (2008) (151)
Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial (2002) (148)
Short report: proximity to mosquito breeding sites as a risk factor for clinical malaria episodes in an urban cohort of Ugandan children. (2003) (147)
Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. (2012) (144)
Artemisinin versus Nonartemisinin Combination Therapy for Uncomplicated Malaria: Randomized Clinical Trials from Four Sites in Uganda (2005) (135)
Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. (2009) (133)
Leveraging Rapid Community-Based HIV Testing Campaigns for Non-Communicable Diseases in Rural Uganda (2012) (131)
Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial (2001) (130)
Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals. (2008) (129)
Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria in Uganda (2006) (124)
Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. (2006) (124)
Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa (2017) (122)
Men “missing” from population-based HIV testing: insights from qualitative research (2016) (121)
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. (2009) (120)
Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children (2014) (120)
Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. (2014) (117)
Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children (2004) (116)
IFNγ/IL-10 Co-producing Cells Dominate the CD4 Response to Malaria in Highly Exposed Children (2014) (115)
Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial (2004) (112)
A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial (2011) (111)
Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda (2007) (108)
Measures of Malaria Burden after Long-Lasting Insecticidal Net Distribution and Indoor Residual Spraying at Three Sites in Uganda: A Prospective Observational Study (2016) (108)
Asymptomatic Plasmodium Infection and Cognition among Primary Schoolchildren in a High Malaria Transmission Setting in Uganda (2013) (105)
Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. (2012) (104)
Acceptance of Routine Testing for HIV among Adult Patients at the Medical Emergency Unit at a National Referral Hospital in Kampala, Uganda (2007) (104)
Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda. (2007) (104)
Loss and dysfunction of Vδ2+ γδ T cells are associated with clinical tolerance to malaria (2014) (102)
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort (2011) (102)
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial (2009) (101)
Mind the Gap: House Structure and the Risk of Malaria in Uganda (2015) (100)
Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. (2016) (100)
Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children (2007) (99)
A hybrid mobile HIV testing approach for population-wide HIV testing in rural East Africa: an observational study (2016) (98)
Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children. (2014) (98)
Indoor Residual Spraying of Insecticide and Malaria Morbidity in a High Transmission Intensity Area of Uganda (2012) (98)
A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. (1998) (96)
Gay and Bisexual Men in Kampala, Uganda (2008) (93)
Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda (2012) (92)
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. (2006) (92)
“How can I tell?” Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV “test-and-treat” trial (2016) (90)
Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children (2007) (90)
Relationship between age, molecular markers, and response to sulphadoxine–pyrimethamine treatment in Kampala, Uganda (2004) (89)
Impact of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine on Malaria in Ugandan Schoolchildren: A Randomized, Placebo-Controlled Trial (2014) (88)
Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure (2017) (87)
Urban malaria: primary caregivers’ knowledge, attitudes, practices and predictors of malaria incidence in a cohort of Ugandan children (2003) (86)
Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, Uganda (2009) (85)
Increasing antimalarial drug resistance in Uganda and revision of the national drug policy (2002) (84)
Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign (2020) (84)
Increasing Condom Use Without Reducing HIV Risk: Results of a Controlled Community Trial in Uganda (2005) (82)
Improved Malaria Case Management through the Implementation of a Health Facility-Based Sentinel Site Surveillance System in Uganda (2011) (82)
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study (2017) (82)
Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. (2003) (81)
Protective Efficacy and Safety of Three Antimalarial Regimens for the Prevention of Malaria in Young Ugandan Children: A Randomized Controlled Trial (2014) (80)
Uptake of Community-Based HIV Testing during a Multi-Disease Health Campaign in Rural Uganda (2014) (78)
Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. (2003) (76)
High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. (2008) (75)
COVID-19: Shining the Light on Africa (2020) (73)
Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. (2006) (73)
Comparative assessment of five trials of universal HIV testing and treatment in sub‐Saharan Africa (2018) (72)
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? (2020) (71)
THE REAL McCOIL: A method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites (2017) (71)
Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial (2011) (70)
Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda. (2020) (70)
Linkage to HIV Care and Survival Following Inpatient HIV Counseling and Testing (2011) (68)
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial. (2016) (67)
Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda (2016) (66)
A Qualitative Study of Barriers to Enrollment into Free HIV Care: Perspectives of Never-in-Care HIV-Positive Patients and Providers in Rakai, Uganda (2013) (65)
Missed Opportunities for HIV Testing and Late-Stage Diagnosis among HIV-Infected Patients in Uganda (2011) (65)
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study (2020) (64)
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. (2014) (63)
Estimating malaria parasite prevalence from community surveys in Uganda: a comparison of microscopy, rapid diagnostic tests and polymerase chain reaction (2015) (63)
Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. (2000) (62)
High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya (2017) (62)
High levels of retention in care with streamlined care and universal test and treat in East Africa (2016) (61)
The effect of indoor residual spraying on malaria and anemia in a high-transmission area of northern Uganda. (2013) (61)
Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey (2011) (59)
HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children (2010) (59)
A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. (2016) (59)
Burden of tuberculosis in Kampala, Uganda. (2003) (59)
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria (2014) (59)
The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study (2012) (58)
Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda. (2005) (58)
Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study (2013) (58)
Fertility and contraceptive decision-making and support for HIV infected individuals: client and provider experiences and perceptions at two HIV clinics in Uganda (2013) (57)
Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women (2015) (56)
HIV Counseling and Testing Practices at an Urban Hospital in Kampala, Uganda (2006) (56)
Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. (2004) (56)
Monthly sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial (2019) (56)
Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study (2019) (55)
Evaluating linkage to care for hypertension after community‐based screening in rural Uganda (2014) (55)
Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial (2009) (55)
Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children. (2004) (55)
Hair and Plasma Data Show That Lopinavir, Ritonavir, and Efavirenz All Transfer From Mother to Infant In Utero, But Only Efavirenz Transfers via Breastfeeding (2013) (54)
Impact of Antimalarial Treatment and Chemoprevention on the Drug Sensitivity of Malaria Parasites Isolated from Ugandan Children (2015) (54)
The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. (2004) (54)
Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance (2010) (54)
Vδ2+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure (2017) (53)
Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on Antiretroviral Therapy (ART) in sub-Saharan Africa: Frequency and clinical significance (2008) (52)
Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation (2017) (52)
False-Positive Results of Enzyme Immunoassays for Human Immunodeficiency Virus in Patients with Uncomplicated Malaria (2006) (52)
Maternal Nutritional Status Predicts Adverse Birth Outcomes among HIV-Infected Rural Ugandan Women Receiving Combination Antiretroviral Therapy (2012) (51)
“Hurdles on the path to 90-90-90 and beyond”: Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat (2018) (50)
Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study (2020) (49)
Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study (2012) (49)
The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. (2001) (49)
Characterizing microscopic and submicroscopic malaria parasitaemia at three sites with varied transmission intensity in Uganda (2016) (48)
Assessing the impact of indoor residual spraying on malaria morbidity using a sentinel site surveillance system in Western Uganda. (2009) (47)
Rapid improvements to rural Ugandan housing and their association with malaria from intense to reduced transmission: a cohort study (2018) (46)
Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women (2015) (46)
Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial (2015) (46)
Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. (2005) (46)
Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children (2009) (46)
Mentorship needs at academic institutions in resource-limited settings: a survey at makerere university college of health sciences (2011) (46)
Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy (2014) (45)
Determinants of hypertension in a young adult Ugandan population in epidemiological transition—the MEPI-CVD survey (2015) (45)
Sex differences in HIV RNA level and CD4 cell percentage during childhood. (2011) (45)
Evaluation of a comprehensive refresher training program in malaria microscopy covering four districts of Uganda. (2011) (45)
Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV‐infected pregnant and breastfeeding women in tororo, uganda (2014) (45)
Factors Associated with Malaria Parasitemia, Anemia and Serological Responses in a Spectrum of Epidemiological Settings in Uganda (2015) (45)
Factors associated with malaria parasitaemia, malnutrition, and anaemia among HIV-exposed and unexposed Ugandan infants: a cross-sectional survey (2012) (45)
Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services. (2011) (44)
Impact of vector control interventions on malaria transmission intensity, outdoor vector biting rates and Anopheles mosquito species composition in Tororo, Uganda (2019) (44)
Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria (2010) (44)
Why is malaria associated with poverty? Findings from a cohort study in rural Uganda (2016) (44)
Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy: A Cross-Sectional Study from Tororo, Uganda (2013) (43)
Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV (2017) (43)
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children (2008) (43)
Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. (2003) (43)
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study (2021) (43)
Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes (2017) (43)
Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors (2019) (42)
Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. (2014) (42)
Incidence of Malaria and Efficacy of Combination Antimalarial Therapies over 4 Years in an Urban Cohort of Ugandan Children (2010) (41)
A group-based intervention to increase condom use among HIV serodiscordant couples in India, Thailand, and Uganda (2007) (41)
Pareto rules for malaria super-spreaders and super-spreading (2019) (41)
Kidney disease in Uganda: a community based study (2017) (41)
Systematic review of the status of pfhrp2 and pfhrp3 gene deletion, approaches and methods used for its estimation and reporting in Plasmodium falciparum populations in Africa: review of published studies 2010–2019 (2019) (41)
Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda (2016) (41)
Decline of FoxP3+ Regulatory CD4 T Cells in Peripheral Blood of Children Heavily Exposed to Malaria (2015) (40)
Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda (2019) (40)
Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses (2020) (40)
Long-lasting insecticide-treated bed net ownership and use among children under five years of age following a targeted distribution in central Uganda (2014) (40)
Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. (2014) (40)
Early Virologic Failure and the Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Ugandan Children (2011) (40)
Correlates of Unprotected Receptive Anal Intercourse Among Gay and Bisexual Men: Kampala, Uganda (2009) (40)
Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance. (2009) (39)
Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria. (2014) (39)
Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda. (2004) (39)
Provider‐initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable (2009) (39)
Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda (2020) (38)
Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa (2016) (38)
HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children. (2001) (37)
Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children (2017) (37)
Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study (2012) (37)
The Development of Plasmodium falciparum-Specific IL10 CD4 T Cells and Protection from Malaria in Children in an Area of High Malaria Transmission (2017) (36)
Abbreviated HIV counselling and testing and enhanced referral to care in Uganda: a factorial randomised controlled trial (2013) (36)
Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis (2019) (36)
Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya (2016) (36)
Sexual Behaviors Over a 3-Year Period Among Individuals With Advanced HIV/AIDS Receiving Antiretroviral Therapy in an Urban HIV Clinic in Kampala, Uganda (2011) (36)
The High Prevalence of Genital Herpes Among Patients With Genital Ulcer Disease in Uganda (1995) (36)
Delayed Sputum Culture Conversion in Tuberculosis–Human Immunodeficiency Virus–Coinfected Patients With Low Isoniazid and Rifampicin Concentrations (2018) (35)
Three-Year Outcome Data of Second-Line Antiretroviral Therapy in Ugandan Adults: Good Virological Response but High Rate of Toxicity (2009) (35)
LLIN Evaluation in Uganda Project (LLINEUP): factors associated with ownership and use of long-lasting insecticidal nets in Uganda: a cross-sectional survey of 48 districts (2018) (35)
Resurgence of Malaria Following Discontinuation of Indoor Residual Spraying of Insecticide in an Area of Uganda With Previously High-Transmission Intensity (2017) (35)
Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method. (2013) (35)
Fertility desires and unmet need for family planning among HIV infected individuals in two HIV clinics with differing models of family planning service delivery (2015) (35)
Potential for false positive HIV test results with the serial rapid HIV testing algorithm (2012) (35)
Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in Uganda. (2007) (34)
Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/&mgr;l in rural Uganda (2014) (34)
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children (2009) (34)
Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda (2013) (34)
Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome? (2008) (34)
Efficacy and Safety of Fixed-Dose Artesunate-Amodiaquine vs. Artemether-Lumefantrine for Repeated Treatment of Uncomplicated Malaria in Ugandan Children (2014) (34)
Malaria Transmission, Infection, and Disease following Sustained Indoor Residual Spraying of Insecticide in Tororo, Uganda. (2020) (34)
Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial (2018) (33)
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy‐Associated Reduction of Dihydroartemisinin‐Piperaquine Exposure During Malaria Chemoprevention (2017) (33)
Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda. (2008) (33)
Decreases in self-reported alcohol consumption following HIV counseling and testing at Mulago Hospital, Kampala, Uganda (2014) (33)
Accuracy of two malaria rapid diagnostic tests (RDTS) for initial diagnosis and treatment monitoring in a high transmission setting in Uganda. (2015) (33)
Determining health-care facility catchment areas in Uganda using data on malaria-related visits. (2014) (33)
Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda (2018) (32)
Stavudine Toxicity in Women is the Main Reason for Treatment Change in a 3-Year Prospective Cohort of Adult Patients Started on First-Line Antiretroviral Treatment in Uganda (2011) (32)
Profile of T cell immune responses in HIV-infected children from Uganda. (2007) (32)
High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/μL under routine program conditions in Uganda. (2013) (32)
Frequent Malaria Drives Progressive Vδ2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood. (2016) (32)
Forecasting malaria in a highly endemic country using environmental and clinical predictors (2015) (32)
Machine learning to identify persons at high-risk of HIV acquisition in rural Kenya and Uganda. (2019) (31)
K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors (2019) (31)
Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda (2018) (31)
Household Food Insecurity, Maternal Nutritional Status, and Infant Feeding Practices Among HIV-infected Ugandan Women Receiving Combination Antiretroviral Therapy (2014) (31)
Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda (2010) (31)
Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach (2015) (31)
The PROCESS study: a protocol to evaluate the implementation, mechanisms of effect and context of an intervention to enhance public health centres in Tororo, Uganda (2013) (31)
Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda (2016) (30)
Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort (2018) (30)
Plasmodium Species Infecting Children Presenting with Malaria in Uganda. (2017) (30)
Glucose-6-Phosphate Dehydrogenase Status and Risk of Hemolysis in Plasmodium falciparum-Infected African Children Receiving Single-Dose Primaquine (2014) (30)
Evaluation of Dynabeads and Cytospheres Compared With Flow Cytometry to Enumerate CD4+ T Cells in HIV-Infected Ugandans on Antiretroviral Therapy (2008) (30)
Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda (2017) (30)
Yield and Efficiency of Novel Intensified Tuberculosis Case‐Finding Algorithms for People Living with HIV (2019) (29)
Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda (2008) (29)
B cell sub-types following acute malaria and associations with clinical immunity (2016) (29)
Strategies to optimize HIV treatment outcomes in resource-limited settings. (2009) (28)
LLIN Evaluation in Uganda Project (LLINEUP): a cross-sectional survey of species diversity and insecticide resistance in 48 districts of Uganda (2019) (28)
Rheumatic Heart Disease Treatment Cascade in Uganda (2017) (28)
Sex-based differences in clearance of chronic Plasmodium falciparum infection (2020) (28)
Health-seeking behavior for malaria among child and adult headed households in Rakai district, Uganda. (2004) (28)
[Accepted Manuscript] Resurgence of malaria following discontinuation of indoor residual spraying of insecticide in a previously high transmission intensity area of Uganda. (2017) (28)
Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial (2018) (27)
Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children. (2008) (27)
Condom use with casual partners by men in Kampala, Uganda. (1997) (27)
In utero priming of highly functional effector T cell responses to human malaria (2018) (27)
Effect of Nutritional Status on Response to Treatment with Artemisinin-Based Combination Therapy in Young Ugandan Children with Malaria (2011) (27)
Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa. (2019) (27)
Estimation of malaria haplotype and genotype frequencies: a statistical approach to overcome the challenge associated with multiclonal infections (2014) (27)
Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. (2015) (27)
Virologic and Immunologic Outcomes of HIV-Infected Ugandan Children Randomized to Lopinavir/Ritonavir or Nonnucleoside Reverse Transcriptase Inhibitor Therapy (2014) (27)
Doctoral training in Uganda: evaluation of mentoring best practices at Makerere university college of health sciences (2014) (27)
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. (2015) (27)
LLIN Evaluation in Uganda Project (LLINEUP) – Impact of long-lasting insecticidal nets with, and without, piperonyl butoxide on malaria indicators in Uganda: study protocol for a cluster-randomised trial (2019) (26)
Traditional Healers for HIV/AIDS Prevention and Family Planning, Kiboga District, Uganda: Evaluation of a Program to Improve Practices (2005) (26)
HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. (2021) (26)
Quantifying Heterogeneous Malaria Exposure and Clinical Protection in a Cohort of Ugandan Children. (2016) (26)
Clinical consequences of submicroscopic malaria parasitaemia in Uganda (2018) (25)
Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda (2012) (25)
Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women (2017) (25)
Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation (2016) (25)
Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda (2016) (25)
Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis (2020) (25)
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial (2014) (25)
The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda. (2009) (25)
Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial. (2019) (24)
The Effect of Malnutrition on the Pharmacokinetics and Virologic Outcomes of Lopinavir, Efavirenz and Nevirapine in Food Insecure HIV-infected Children in Tororo, Uganda (2015) (24)
Multiple Sexual Partnerships Among Poor Urban Dwellers in Kampala, Uganda (2011) (24)
Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda (2014) (24)
Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity (2016) (24)
Bacteremia among Febrile Ugandan Children Treated with Antimalarials Despite a Negative Malaria Test (2015) (24)
First-line antiretroviral therapy in Africa--how evidence-base are our recommendations? (2005) (24)
Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings (2011) (24)
Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda (2015) (24)
Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance–Mediating Polymorphisms in Uganda (2017) (24)
Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy (2017) (23)
Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda (2013) (23)
Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda. (2014) (22)
Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes. (2010) (22)
Trends of admissions and case fatality rates among medical in-patients at a tertiary hospital in Uganda; A four-year retrospective study (2019) (22)
Malaria in Uganda: challenges to control on the long road to elimination. II. The path forward. (2012) (21)
Comparative effectiveness of novel nonmonetary incentives to promote HIV testing (2018) (21)
Effective Antimalarial Chemoprevention in Childhood Enhances the Quality of CD4+ T Cells and Limits Their Production of Immunoregulatory Interleukin 10. (2016) (21)
Persistent Parasitemia Despite Dramatic Reduction in Malaria Incidence After 3 Rounds of Indoor Residual Spraying in Tororo, Uganda (2018) (21)
Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda (2011) (21)
First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda (2016) (21)
Population Levels and Geographic Distribution of HIV RNA in Rural Ugandan and Kenyan Communities and Sero-Discordant Couples: a Cross-Sectional Analysis (2016) (21)
Measuring Socioeconomic Inequalities in Relation to Malaria Risk: A Comparison of Metrics in Rural Uganda. (2016) (21)
Population genomics of virulence genes of Plasmodium falciparum in clinical isolates from Uganda (2017) (21)
Molecular surveillance reveals the presence of pfhrp2 and pfhrp3 gene deletions in Plasmodium falciparum parasite populations in Uganda, 2017–2019 (2020) (21)
Interaction of malaria and HIV in Africa (2009) (21)
A decade of antiretroviral therapy in Uganda: what are the emerging causes of death? (2019) (21)
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children (2016) (20)
LLIN Evaluation in Uganda Project (LLINEUP): factors associated with childhood parasitaemia and anaemia 3 years after a national long-lasting insecticidal net distribution campaign: a cross-sectional survey (2019) (20)
The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study (2020) (20)
The impact of stopping and starting indoor residual spraying on malaria burden in Uganda (2021) (20)
Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort (2013) (20)
Geographic differences in the prevalence of hypertension in Uganda: Results of a national epidemiological study (2018) (20)
Household and maternal risk factors for malaria in pregnancy in a highly endemic area of Uganda: a prospective cohort study (2019) (20)
High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort (2014) (19)
Associations between urbanicity and malaria at local scales in Uganda (2015) (19)
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria. (2010) (19)
Estradiol Levels Are Altered in Human Immunodeficiency Virus–Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy (2017) (19)
Monthly Sulfadoxine–Pyrimethamine Versus Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of Malaria in Pregnancy: A Double-blind, Randomised, Controlled, Superiority Trial (2019) (18)
The PRIME trial protocol: evaluating the impact of an intervention implemented in public health centres on management of malaria and health outcomes of children using a cluster-randomised design in Tororo, Uganda (2013) (18)
Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children (2015) (18)
Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. (2010) (18)
Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial. (2014) (18)
Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda (2017) (18)
Prevalence and factors associated with asthma among adolescents and adults in Uganda: a general population based survey (2019) (18)
Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial (2018) (18)
Brief Report: Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan Women (2016) (18)
Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine (2018) (18)
Health facility-based malaria surveillance: The effects of age, area of residence and diagnostics on test positivity rates (2012) (18)
Health care related factors associated with severe malaria in children in Kampala, Uganda. (2009) (18)
Behind the scenes of the PRIME intervention: designing a complex intervention to improve malaria care at public health centres in Uganda (2015) (18)
Predictors of Retention in HIV Care Among Youth (15–24) in a Universal Test-and-Treat Setting in Rural Kenya (2017) (17)
Changes in Population HIV RNA Levels in Mbarara, Uganda, During Scale-up of HIV Antiretroviral Therapy Access (2014) (17)
Gaps in the child tuberculosis care cascade in 32 rural communities in Uganda and Kenya (2017) (17)
Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. (2019) (17)
Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis. (2013) (17)
Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90% of HIV-Infected Individuals (2019) (17)
Non-adherence to long-lasting insecticide treated bednet use following successful malaria control in Tororo, Uganda (2020) (17)
The Impact of an Intervention to Improve Malaria Care in Public Health Centers on Health Indicators of Children in Tororo, Uganda (PRIME): A Cluster-Randomized Trial (2016) (17)
Evaluating the feasibility and uptake of a community-led HIV testing and multi-disease health campaign in rural Uganda (2017) (17)
Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys (2018) (17)
A need to accelerate health research productivity in an African University: the case of Makerere University College of Health Sciences (2017) (16)
Opsonized antigen activates Vδ2+ T cells via CD16/FCγRIIIa in individuals with chronic malaria exposure (2020) (16)
The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa. (2012) (16)
Impact of microscopic and submicroscopic parasitemia during pregnancy on placental malaria in a high-transmission setting in Uganda. (2019) (16)
Anti-malarial prescription practices among children admitted to six public hospitals in Uganda from 2011 to 2013 (2015) (16)
A Human-Centered Approach to CV Care (2018) (15)
Performance of Loop-Mediated Isothermal Amplification for the Identification of Submicroscopic Plasmodium falciparum Infection in Uganda. (2017) (15)
Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda. (2016) (15)
Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda (2015) (15)
Impact of seasonality and malaria control interventions on Anopheles density and species composition from three areas of Uganda with differing malaria endemicity (2020) (15)
A Cross-Cutting Approach to Surveillance and Laboratory Capacity as a Platform to Improve Health Security in Uganda. (2018) (15)
The reliability and validity of the Modified Condom Outcome Expectancy Scale (MCOES) among an international sample of HIV-negative partners of people living with HIV/AIDS (2003) (14)
Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study (2018) (14)
Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus–Infected Women Receiving Efavirenz (2018) (14)
Spatio-temporal analysis of malaria vector density from baseline through intervention in a high transmission setting (2016) (14)
Measuring the Outcomes of a Comprehensive HIV Care Course: Pilot Test at the Infectious Diseases Institute, Kampala, Uganda (2006) (14)
Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda. (2004) (14)
Free Antiretrovirals Must Not Be Restricted Only to Treatment-Naive Patients (2005) (14)
Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda. (2014) (14)
Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial (2020) (14)
IFNγ Responses to Pre-erythrocytic and Blood-stage Malaria Antigens Exhibit Differential Associations With Past Exposure and Subsequent Protection. (2015) (14)
Malaria Burden through Routine Reporting: Relationship between Incidence and Test Positivity Rates. (2019) (14)
A patient-centered multi-component strategy for accelerated linkage to care following community-wide HIV testing in rural Uganda and Kenya. (2019) (14)
Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients. (2007) (14)
Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients (2017) (14)
Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children. (2014) (14)
Breastfeeding and the Risk of Malaria in Children Born to HIV-Infected and Uninfected Mothers in Rural Uganda (2010) (14)
The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children. (2013) (14)
A Novel, 5-Transcript, Whole-blood Gene-expression Signature for Tuberculosis Screening Among People Living With Human Immunodeficiency Virus. (2018) (14)
Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry (2017) (14)
Comparison of routine health management information system versus enhanced inpatient malaria surveillance for estimating the burden of malaria among children admitted to four hospitals in Uganda. (2015) (13)
The impact of multiple rounds of indoor residual spraying on malaria incidence and haemoglobin levels in a high transmission setting. (2019) (13)
Among Patients with Sustained Viral Suppression in a Resource-Limited Setting, CD4 Gains Are Continuous Although Gender-Based Differences Occur (2013) (13)
Assessing temporal associations between environmental factors and malaria morbidity at varying transmission settings in Uganda (2016) (13)
Exposure to pesticides in utero impacts the fetal immune system and response to vaccination in infancy (2021) (13)
Pathways for reduction of HIV‐related stigma: a model derived from longitudinal qualitative research in Kenya and Uganda (2020) (13)
Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda (2013) (13)
Redemption of the “spoiled identity:” the role of HIV‐positive individuals in HIV care cascade interventions (2017) (13)
Group Mentorship Model to Enhance the Efficiency and Productivity of PhD Research Training in Sub-Saharan Africa (2018) (13)
Association Between Recent Overnight Travel and Risk of Malaria: A Prospective Cohort Study at 3 Sites in Uganda (2018) (13)
The impact of gravidity, symptomatology and timing of infection on placental malaria (2020) (13)
Impact of vector control interventions on malaria transmission intensity, outdoor vector biting rates and Anopheles mosquito species composition in Tororo, Uganda (2019) (13)
Short-Term Risk of HIV Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapy (2010) (13)
Heterogeneous exposure and hotspots for malaria vectors at three study sites in Uganda (2018) (12)
Impact of Patient-Selected Care Buddies on Adherence to HIV Care, Disease Progression, and Conduct of Daily Life Among Pre-antiretroviral HIV-Infected Patients in Rakai, Uganda: A Randomized Controlled Trial (2015) (12)
Sex Disparity in Cord Blood FoxP3+ CD4 T Regulatory Cells in Infants Exposed to Malaria In Utero (2017) (12)
Phenotypic characteristics and asthma severity in an East African cohort of adults and adolescents with asthma: findings from the African severe asthma project (2020) (12)
The impact of an intervention to introduce malaria rapid diagnostic tests on fever case management in a high transmission setting in Uganda: A mixed-methods cluster-randomized trial (PRIME) (2017) (12)
A Novel Model of Asymptomatic Plasmodium Parasitemia That Recapitulates Elements of the Human Immune Response to Chronic Infection (2016) (12)
Is that a real oocyst? Insectary establishment and identification of Plasmodium falciparum oocysts in midguts of Anopheles mosquitoes fed on infected human blood in Tororo, Uganda (2019) (12)
Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda (2018) (12)
Rapid shifts in the age-specific burden of malaria following successful control interventions in four regions of Uganda (2019) (12)
Dimensions of HIV-related stigma in rural communities in Kenya and Uganda at the start of a large HIV ‘test and treat’ trial (2021) (12)
The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs. (2018) (12)
The Impact of Control Interventions on Malaria Burden in Young Children in a Historically High-Transmission District of Uganda: A Pooled Analysis of Cohort Studies from 2007 to 2018 (2020) (12)
Global medical education partnerships to expand specialty expertise: a case report on building neurology clinical and research capacity (2014) (12)
Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. (2013) (12)
Impact of COVID-19 on routine malaria indicators in rural Uganda: an interrupted time series analysis (2021) (11)
Limitations of rapid diagnostic tests in malaria surveys in areas with varied transmission intensity in Uganda 2017-2019: Implications for selection and use of HRP2 RDTs (2020) (11)
Quality of Inpatient Pediatric Case Management for Four Leading Causes of Child Mortality at Six Government-Run Ugandan Hospitals (2015) (11)
OUTCOMES OF CRYPTOCOCCAL MENINGITIS IN UGANDA BEFORE AND AFTER THE AVAILABILITY OF HAART (2008) (11)
Evaluation of a Predictive Staging Model for HIV-Associated Kaposi Sarcoma in Uganda (2017) (11)
Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda (2018) (11)
Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda. (2012) (11)
Prevalence, associated factors and perspectives of HIV testing among men in Uganda (2020) (11)
Marked variation in prevalence of malaria-protective human genetic polymorphisms across Uganda. (2017) (11)
Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the search study. (2018) (11)
Relationships between measures of malaria at delivery and adverse birth outcomes in a high-transmission area of Uganda. (2020) (11)
A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya (2018) (11)
Leveraging incentives to increase HIV testing uptake among men: qualitative insights from rural Uganda (2019) (11)
Prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites in countries affected by malaria disease since change of treatment policy: a systematic review protocol (2018) (10)
Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. (2009) (10)
Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy (2019) (10)
Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. (2019) (10)
Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant Women (2020) (10)
Assessing the Quality of Tuberculosis Evaluation for Children with Prolonged Cough Presenting to Routine Community Health Care Settings in Rural Uganda (2014) (10)
The impact of HIV on the prevalence of asthma in Uganda: a general population survey (2018) (9)
Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy (2016) (9)
Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention in the SEARCH trial (2016) (9)
HIV RNA suppression among HIV-infected Ugandan children with measles. (2008) (9)
Reaching 90-90-90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health Trial. (2019) (9)
Two-Stage TMLE to reduce bias and improve efficiency in cluster randomized trials (2021) (9)
Financial incentives and deposit contracts to promote HIV retesting in Uganda: A randomized trial (2021) (9)
Associations between red blood cell variants and malaria among children and adults from three areas of Uganda: a prospective cohort study (2020) (9)
Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort. (2014) (9)
Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda (2018) (9)
Neonatal mortality in HIV-exposed infants born to women receiving combination antiretroviral therapy in Rural Uganda. (2013) (9)
Regional differences in predictive accuracy of WHO immunologic failure criteria (2012) (9)
The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda (2020) (8)
Case studies in ethics and HIV research (2007) (8)
HIV-1 Infection in Patients Referred for Malaria Blood Smears at Government Health Clinics in Uganda (2007) (8)
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda (2021) (8)
Relationships between test positivity rate, total laboratory confirmed cases of malaria, and malaria incidence in high burden settings of Uganda: an ecological analysis (2020) (8)
Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda (2011) (8)
Men’s Beliefs About the Likelihood of Serodiscordance in Couples with an HIV-Positive Partner: Survey Evidence from Rural Uganda (2020) (8)
Identification and characterization of immature Anopheles and culicines (Diptera: Culicidae) at three sites of varying malaria transmission intensities in Uganda (2020) (8)
Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT) (2019) (7)
Impact of a Rapid Decline in Malaria Transmission on Antimalarial IgG Subclasses and Avidity (2020) (7)
A pilot randomized trial of incentive strategies to promote HIV retesting in rural Uganda (2020) (7)
Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda (2020) (7)
Association between recent overnight travel and use of long-lasting insecticidal nets in rural Uganda: a prospective cohort study in Tororo (2020) (7)
Mobile, Population-wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda (2018) (7)
Lung Function of Children at Three Sites of Varying Ambient Air Pollution Levels in Uganda: A Cross Sectional Comparative Study (2018) (7)
Associations between environmental covariates and temporal changes in malaria incidence in high transmission settings of Uganda: a distributed lag nonlinear analysis (2021) (7)
Cost and efficiency of a hybrid mobile multi-disease testing approach with high HIV testing coverage in East Africa. (2016) (7)
Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study (2016) (7)
Gender difference in the incidence of malaria diagnosed at public health facilities in Uganda (2021) (7)
Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, Uganda (2014) (7)
O087 Leveraging existing HIV/AIDS infrastructure for rheumatic heart disease care in Uganda: a collaborative disease surveillance and management program (2014) (7)
Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation (2020) (7)
Comparative Prevalence of Plasmodium falciparum Resistance-Associated Genetic Polymorphisms in Parasites Infecting Humans and Mosquitoes in Uganda. (2017) (7)
Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda (2014) (7)
The prevalence of histologic acute chorioamnionitis among HIV infected pregnant women in Uganda and its association with adverse birth outcomes (2019) (7)
Far from MCAR: obtaining population-level estimates of HIV viral suppression (2019) (6)
Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole (2019) (6)
HLA Alleles B*53:01 and C*06:02 Are Associated With Higher Risk of P. falciparum Parasitemia in a Cohort in Uganda (2021) (6)
Estimating malaria incidence from routine health facility-based surveillance data in Uganda (2020) (6)
Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda (2021) (6)
Protective Effect of Indoor Residual Spraying of Insecticide on Preterm Birth Among Pregnant Women With HIV Infection in Uganda: A Secondary Data Analysis (2017) (6)
Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda. (2006) (6)
Uptake and outcomes of a novel community‐based HIV post‐exposure prophylaxis (PEP) programme in rural Kenya and Uganda (2021) (6)
Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya (2019) (5)
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens (2015) (5)
Implementation of a Newborn Clinical Decision Support Software (NoviGuide) in a Rural District Hospital in Eastern Uganda: Feasibility and Acceptability Study (2021) (5)
High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda (2020) (5)
Resurgence of malaria in Uganda despite sustained indoor residual spraying and repeated long lasting insecticidal net distributions (2022) (5)
Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda (2021) (5)
Response to comment on “Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)” (2012) (5)
Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda (2017) (5)
Post-traumatic stress disorder among persons with HIV who engage in heavy alcohol consumption in southwestern Uganda (2021) (5)
Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from Uganda (2021) (5)
Hypertension care cascade at a large urban HIV clinic in Uganda: a mixed methods study using the Capability, Opportunity, Motivation for Behavior change (COM-B) model (2020) (5)
Gravidity-dependent associations between interferon response and birth weight in placental malaria (2016) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
Routine HIV testing: the right not to know versus the rights to care, treatment and prevention (2007) (5)
Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care (2017) (5)
Planning prompts to promote uptake of HIV services among men: a randomised trial in rural Uganda (2020) (5)
The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda. (2020) (5)
Effect of a Patient-Centered Phone Call by a Clinical Officer at Time of HIV Testing on Linkage to Care in Rural Kenya (2018) (5)
Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia? (2008) (5)
Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study (2020) (5)
High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial (2018) (5)
Supporting capacity for research on malaria in Africa (2018) (5)
Practical Implications of a Relationship between Health Management Information System and Community Cohort-Based Malaria Incidence Rates. (2020) (5)
Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda (2020) (5)
Brief Report: Yield and Efficiency of Intensified Tuberculosis Case-Finding Algorithms in 2 High-Risk HIV Subgroups in Uganda. (2019) (4)
K13-propeller gene polymorphisms in Plasmodium falciparum parasite population: a systematic review protocol of burden and associated factors (2018) (4)
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin–piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data (2020) (4)
Within‐household clustering of genetically related Plasmodium falciparum infections in a moderate transmission area of Uganda (2020) (4)
Genetic diversity and genetic relatedness in Plasmodium falciparum parasite population in individuals with uncomplicated malaria based on microsatellite typing in Eastern and Western regions of Uganda, 2019–2020 (2021) (4)
Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin‐Piperaquine as Malaria Chemoprevention (2019) (4)
Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy (2020) (4)
Generation of a malaria negative Ugandan birth weight standard for the diagnosis of small for gestational age (2020) (4)
Estimating the optimal interval between rounds of indoor residual spraying of insecticide using malaria incidence data from cohort studies (2020) (4)
Association of Inhibitory Killer Cell Immunoglobulin-like Receptor Ligands With Higher Plasmodium falciparum Parasite Prevalence (2020) (4)
Case Report: Birth Outcome and Neurodevelopment in Placental Malaria Discordant Twins. (2019) (4)
The Changing Landscape of Malaria Case Management in Uganda: Decades of Struggle with Evolving Malaria Case Management Strategies and Drug Policies (2014) (4)
Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy. (2020) (4)
Sustainability of the streamlined ART (START-ART) implementation intervention strategy among ART-eligible adult patients in HIV clinics in public health centers in Uganda: a mixed methods study (2020) (4)
Do clinicians in areas of declining malaria transmission adhere to malaria diagnosis guidelines? A cross-sectional study from Kampala, Uganda (2020) (4)
Measures of malaria transmission, infection, and disease in an area bordering two districts with and without sustained indoor residual spraying of insecticide in Uganda (2022) (4)
Behind the scenes of the PRIME intervention: designing a complex intervention to improve malaria care at public health centres in Uganda (2015) (4)
Infant sex modifies associations between placental malaria and risk of malaria in infancy (2020) (4)
Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda (2016) (4)
SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts. (2021) (3)
LLIN evaluation in Uganda project (LLINEUP): The fabric integrity, chemical content and bioefficacy of long-lasting insecticidal nets treated with and without piperonyl butoxide across two years of operational use in Uganda (2022) (3)
Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS. (2013) (3)
Malaria Diagnosed in an Urban Setting Strongly Associated with Recent Overnight Travel: A Case-Control Study from Kampala, Uganda. (2020) (3)
Antimalarial drug resistance: a critical problem for Sub-Saharan Africa (2001) (3)
Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda (2013) (3)
LLIN Evaluation in Uganda Project (LLINEUP) – The durability of long-lasting insecticidal nets treated with and without piperonyl butoxide (PBO) in Uganda (2022) (3)
Reaching 90–90–90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health Trial (2019) (3)
Home management of malaria – Authors' reply (2009) (3)
Reducing turnaround time for laboratory test results does not improve retention of stable HIV-infected adults on POV program: experience from Uganda (2014) (3)
Age-Related Changes in Malaria Clinical Phenotypes During Infancy Are Modified by Sickle Cell Trait (2021) (3)
Assessment of the accuracy of malaria microscopy in private health facilities in Entebbe Municipality, Uganda: a cross-sectional study (2021) (3)
Changing malaria fever test positivity among paediatric admissions to Tororo district hospital, Uganda 2012–2019 (2020) (3)
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children (2021) (3)
Costs of integrating hypertension care into HIV care in rural East African clinics (2021) (3)
Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives (2020) (3)
Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya (2021) (3)
Completion of isoniazid–rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness–implementation randomized trial (2021) (3)
Are the best antiretrovirals being used in Africa? (2006) (3)
Erratum to: B cell sub-types following acute malaria and associations with clinical immunity (2016) (3)
Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity (2020) (3)
Gestational age dating using newborn metabolic screening: A validation study in Busia, Uganda (2021) (3)
“I was still very young”: agency, stigma and HIV care strategies at school, baseline results of a qualitative study among youth in rural Kenya and Uganda (2022) (3)
Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women (2020) (3)
Prophylaxis and treatment of malaria in HIV-infected populations (2008) (3)
Sub-optimal CD 4 reconstitution despite viral suppression in an urban cohort on Antiretroviral Therapy ( ART ) in sub-Saharan Africa : Frequency and clinical significance (2015) (2)
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data (2022) (2)
Integration of Routine HIV Testing with TB Diagnosis Among Medical Inpatients in Mulago Hospital, Uganda (2008) (2)
Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda (2022) (2)
Far from MCAR (2020) (2)
Predicting Malaria in a Highly Endemic Country using Environmental and Clinical Data Sources (2014) (2)
Mechanisms driving altered v delta 2+gamma delta t cell function during recurrent malaria infection (2019) (2)
Impact of mycobacterial culture among HIV-infected adults with presumed TB in Uganda: a prospective cohort study. (2015) (2)
In Utero Activation of Natural Killer Cells in Congenital Cytomegalovirus Infection (2022) (2)
Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study (2021) (2)
Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial (2021) (2)
Inhibitory KIR ligands are associated with higher P. falciparum parasite prevalence. (2020) (2)
Vδ2+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure (2017) (2)
Effect of universal HIV testing and treatment on socioeconomic wellbeing in rural Kenya and Uganda: a cluster-randomised controlled trial (2022) (2)
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
Delayed sputum conversation in TB-HIV co-infected patients with low isoniazid and rifampicin concentrations (2017) (2)
Effect of malaria and malaria chemoprevention regimens in pregnancy and childhood on neurodevelopmental and behavioral outcomes in children at 12, 24 and 36 months: a randomized clinical trial. (2022) (2)
Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda. (2022) (2)
Heterogeneous Exposure and Hotspots for Malaria Vectors at Three Study Sites in Uganda (2018) (2)
Social Networks and HIV Care Outcomes in Rural Kenya and Uganda (2021) (2)
Semi-Supervised Record Linkage for Construction of Large-Scale Sociocentric Networks in Resource-limited Settings: An application to the SEARCH Study in Rural Uganda and Kenya (2019) (2)
WHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity. (2013) (2)
Provider and Patient Perspectives of Rapid ART Initiation and Streamlined HIV Care: Qualitative Insights From Eastern African Communities (2021) (2)
Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial. (2020) (2)
Distinct forms of migration and mobility are differentially associated with HIV treatment adherence (2022) (2)
Asymptomatic School-Aged Children Are Important Drivers of Malaria Transmission in a High Endemicity Setting in Uganda (2022) (2)
Gametocyte production in incident P. falciparum infections: a longitudinal study in a low transmission setting under intensive vector control (2022) (1)
Evaluation of home-based management of fever in urban Ugandan children (2006) (1)
Implementation of a Newborn Clinical Decision Support Software (NoviGuide) in a Rural District Hospital in Eastern Uganda: Feasibility and Acceptability Study (Preprint) (2020) (1)
Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3 months weekly isoniazid-rifapentine (2023) (1)
Estimation of malaria haplotype and genotype frequencies: a statistical approach to overcome the challenge associated with multiclonal infections (2014) (1)
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda (2017) (1)
PEP for HIV prevention: are we missing opportunities to reduce new infections? (2022) (1)
Condom, modern contraceptive, and dual method use are associated with HIV status and relationship concurrency in a context of high mobility: A cross-sectional study of women of reproductive age in rural Kenya and Uganda, 2016. (2022) (1)
Identification and characterization of Anopheles larval aquatic habitats at three sites of varying malaria transmission intensities in Uganda. (2020) (1)
An assessment of implementation science research capacity in Uganda (2021) (1)
Impact of different mosquito collection methods on indicators of Anopheles malaria vectors in Uganda (2022) (1)
Condom Use Between HIV Serology Discordant Couples in Kampala (2000) (1)
Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children (2017) (1)
Concordance Between Point-of-Care Urine Ethyl Glucuronide Alcohol Tests and Self-Reported Alcohol Use in Persons with HIV in Uganda (2022) (1)
The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study (2012) (1)
Soluble Markers of B-Cell Stimulation During Asymptomatic and Symptomatic Malaria Parasitemia in Children in Uganda (2016) (1)
Population genomics of virulence genes of Plasmodium falciparum in clinical isolates from Uganda (2017) (1)
Two or more significant life-events in 6-months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya (2022) (1)
Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): final results of a cluster-randomised trial embedded in a national distribution campaign. (2022) (1)
Prevalence of COPD in a sub-Saharan country: Fresh Air Uganda survey (2014) (1)
LLIN Evaluation in Uganda Project (LLINEUP): a cross-sectional survey of species diversity and insecticide resistance in 48 districts of Uganda (2019) (1)
Integrated malaria prevention in low- and middle-income countries: a systematic review (2023) (1)
Evaluation of the AIDS clinical trials group staging criteria for Kaposi Sarcoma in a resource limited setting (2012) (1)
Track E Implementation Science, Health Systems and Economics (2012) (1)
Potential for false positive HIV test results with the serial rapid HIV testing algorithm (2012) (1)
Track E Implementation Science, Health Systems and Economics (2012) (1)
House design and risk of malaria, acute respiratory infection and gastrointestinal illness in Uganda: A cohort study (2022) (1)
Track E Implementation Science, Health Systems and Economics (2012) (1)
HIV retesting and risk behaviors among high-risk, HIV-uninfected adults in Uganda (2020) (1)
Author response: Sex-based differences in clearance of chronic Plasmodium falciparum infection (2020) (1)
Doctoral training in Uganda: evaluation of mentoring best practices at Makerere university college of health sciences (2014) (1)
Track D Social Science, Human Rights and Political Science (2012) (1)
Closing the NIH Fogarty Center threatens US and global health (2017) (1)
Associations between environmental covariates and malaria incidence in high transmission settings of Uganda: A distributed non-linear lagged ecological analysis (2021) (1)
Targeted Newborn Metabolomics: Prediction of gestational age from cord blood (2021) (1)
A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial (2022) (1)
Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort (2013) (1)
Improved Viral Suppression With Streamlined Care in the SEARCH Study (2020) (1)
Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity (2021) (1)
Factors associated with malaria parasitaemia, malnutrition, and anaemia among HIV-exposed and unexposed Ugandan infants: a cross-sectional survey (2012) (1)
Marked reduction in antibiotic usage following intensive malaria control in a cohort of Ugandan children (2021) (1)
Abstract 18798: Application of the HIV/AIDS Treatment Cascade Model to Rheumatic Heart Disease in Uganda (2014) (1)
Closing the gap: A novel metric of change in performance. (2019) (1)
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children (2016) (0)
Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children (2015) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting (2016) (0)
Randomized controlled trials of the plastic housing biosand filter in Cambodia, Ghana and Honduras (2015) (0)
Demographic Influence on the Evolution of Antiretroviral Therapy (ART) (2015) (0)
Mentoring for sustainable in-country academic leadership in resource-limited settings (2015) (0)
Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT) (2019) (0)
Intermittent preventive treatment with dihydroartemisinin-piperaquine in young Ugandan children and risk of malaria following cessation: A randomised controlled trial (2019) (0)
Simulating the Impacts of Augmenting Intensive Vector Control with Mass Drug Administration or Test-and-Treat Strategies on the Malaria Infectious Reservoir. (2022) (0)
Remote bednet use monitoring to describe patterns of use and exposure to female Anopheles mosquitoes in an Ugandan cohort (2022) (0)
Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda (2017) (0)
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria (2014) (0)
Association between recent overnight travel and use of long-lasting insecticidal nets in rural Uganda: a prospective cohort study in Tororo (2020) (0)
Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors (2019) (0)
Evaluation of the AIDS clinical trials group staging criteria for Kaposi Sarcoma in a resource limited setting (2012) (0)
Ivermectin for mass drug administration against malaria. (2021) (0)
Effect of a one-time financial incentive on linkage to chronic hypertension care in Kenya and Uganda: A randomized controlled trial (2022) (0)
Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting (2016) (0)
F RACTION OF F EVER IN C OHORT S TUDIES THROUGH A B EFORE AND A FTER C OMPARISON OF I MPACT : N AGONGERA , T ORORO , U GANDA 2011-2019 (2022) (0)
Plasmodium falciparum gametocyte carriage in longitudinally monitored incident infections is associated with duration of infection and human host factors (2023) (0)
The Prevalence of Disseminated Tuberculosis Among Tuberculosis Patients in Uganda (2021) (0)
Spatio-temporal analysis of malaria vector density from baseline through intervention in a high transmission setting (2016) (0)
Characterizing pyrethroid resistance and mechanisms in Anopheles gambiae (s.s.) and Anopheles arabiensis from 11 districts in Uganda (2022) (0)
Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda (2020) (0)
Health facility-based malaria surveillance: The effects of age, area of residence and diagnostics on test positivity rates (2012) (0)
High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort (2014) (0)
Assessment of the accuracy of malaria microscopy in private health facilities in Entebbe Municipality, Uganda: a cross-sectional study (2021) (0)
Anti-malarial prescription practices among children admitted to six public hospitals in Uganda from 2011 to 2013 (2015) (0)
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda (2021) (0)
Impact of COVID-19 on routine malaria indicators in rural Uganda: an interrupted time series analysis (2021) (0)
Associations between urbanicity and malaria at local scales in Uganda (2015) (0)
Estimating malaria parasite prevalence from community surveys in Uganda: a comparison of microscopy, rapid diagnostic tests and polymerase chain reaction (2015) (0)
Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes (2017) (0)
Deletions of pfhrp 2 and pfhrp 3 genes in rapid diagnostic test-negative Plasmodium 1 falciparum isolates from Uganda 2 (2020) (0)
Ugandan schoolchildren selects for Plasmodium falciparum transporter (2016) (0)
Evaluation ofWHOCriteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings (2014) (0)
Effects of a COVID-19 Public Health Lockdown on Drinking and Health Behavior Among Persons with HIV and with Unhealthy Alcohol use in Uganda (2023) (0)
CONCURRENTLY ESTIMATING THE COMPLEXITY OF INFECTION AND SNP ALLELE FREQUENCY FOR MALARIA PARASITES (2017) (0)
LLIN Evaluation in Uganda Project (LLINEUP): factors associated with ownership and use of long-lasting insecticidal nets in Uganda: a cross-sectional survey of 48 districts (2018) (0)
East Africa International Center of Excellence for Malaria Research: Summary of Key Research Findings (2022) (0)
Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda (2012) (0)
Erratum: Evaluation of a low-cost method, the guava easyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and Uganda (Journal of Acquired Immune Deficiency Syndrome (2006) 41, 5 (607-610)) (2006) (0)
Clinical Presentation and Bacteriology of Diabetic Foot Ulcers at Mulago Hospital: A Prospective Case Series Study. (0)
Effects of anti-malarial prophylaxes on maternal transfer of Immunoglobulin-G (IgG) and association to immunity against Plasmodium falciparum infections among children in a Ugandan birth cohort (2023) (0)
Population-based active TB case finding during large-scale mobile HIV testing campaigns in rural Uganda. (2016) (0)
(UMSP) in partnership with the Uganda National Malaria Control Program embarked on a training program for labo- ratory personnel in malaria microscopy in selected districts with support from the Presidential Malaria Initiative (PMI) (2011) (0)
The prevalence of concurrent pulmonary and extrapulmonary tuberculosis in Uganda: a retrospective study (2022) (0)
The impact of gravidity, symptomatology and timing of infection on placental malaria (2020) (0)
Department of Medicine, University of California, San Francisco (2015) (0)
Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda (2022) (0)
633: Generation of a malaria-negative African birthweight standard for diagnosis of small for gestational age (2020) (0)
Forecasting malaria in a highly endemic country using environmental and clinical predictors (2015) (0)
Anti-Malarial Targeting and Dosing Practices among Health Workers at Lower Level Health Facilities in Uganda (2014) (0)
Malaria Trends in Six Outpatient Sites in Uganda, 2008—2011 (2013) (0)
Systematic review of the status of pfhrp2 and pfhrp3 gene deletion, approaches and methods used for its estimation and reporting in Plasmodium falciparum populations in Africa: review of published studies 2010–2019 (2019) (0)
Early evidence of reduction in all-cause and malaria attributed deaths at health facilities following scale-up of malaria interventions in Uganda 2004-2010 (2014) (0)
Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation (2016) (0)
The impact of stopping and starting indoor residual spraying on malaria burden in 14 districts of Uganda (2020) (0)
Contributors (2012) (0)
Do clinicians in areas of declining malaria transmission adhere to malaria diagnosis guidelines? A cross-sectional study from Kampala, Uganda (2021) (0)
Title Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial Permalink (2018) (0)
Structured career development for global health research in resource-limited settings: A pilot of career development series for faculty at Makerere university college of health sciences (2015) (0)
Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole (2019) (0)
Is that a real oocyst? Insectary establishment and identification of Plasmodium falciparum oocysts in midguts of Anopheles mosquitoes fed on infected human blood in Tororo, Uganda (2019) (0)
Low-cost dynabead and cytospheres compared to FACSCount to monitor patients on antiretroviral therapy at a public clinic in Kampala, Uganda (2006) (0)
Deletions of pfhrp2 and pfhrp3 genes in rapid diagnostic test-negative Plasmodium falciparum isolates from Uganda (2020) (0)
Clinical Significance of Sub-Optimal CD4 Reconstitution Despite Viral Suppression in An Urban Cohort Initiating Antiretroviral Therapy in Sub-Saharan Africa (2008) (0)
Associations between red blood cell variants and malaria among children and adults from three areas of Uganda: a prospective cohort study (2020) (0)
East Africa International Center of Excellence for Malaria Research: Impact on Malaria Policy in Uganda (2022) (0)
Prevalence and factors associated with asthma among adolescents and adults in Uganda (2019) (0)
Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda (2016) (0)
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230 (2023) (0)
Culturally adapting a mindfulness and acceptance-based intervention to support the mental health of adolescents on antiretroviral therapy in Uganda (2023) (0)
Anemia, vitamin B12, and folate statuses during pregnancy, and their association with obstetric outcomes among HIV‐infected Ugandan women receiving ART (804.8) (2014) (0)
LLIN Evaluation in Uganda Project (LLINEUP): factors associated with childhood parasitaemia and anaemia 3 years after a national long-lasting insecticidal net distribution campaign: a cross-sectional survey (2019) (0)
K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors (2019) (0)
Household and maternal risk factors for malaria in pregnancy in a highly endemic area of Uganda: a prospective cohort study (2019) (0)
Feasibility and preliminary effectiveness of integrating HIV prevention into an adolescent empowerment and livelihood intervention at youth clubs in rural Uganda (2022) (0)
Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda (2022) (0)
Mobility is Associated with Higher-risk Sexual Partnerships Among Both Men and Women in Co-resident Couples in Rural Kenya and Uganda: A Longitudinal Cohort Study (2022) (0)
Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda (2014) (0)
Relationships between test positivity rate, total laboratory confirmed cases of malaria, and malaria incidence in high burden settings of Uganda: an ecological analysis (2021) (0)
Metagenomic next-generation sequencing to characterize etiologies of non-malarial fever in a cohort living in a high malaria burden area of Uganda (2022) (0)
Primaquine Children Receiving Single-Dose Plasmodium falciparum-Infected African Status and Risk of Hemolysis in Glucose-6-Phosphate Dehydrogenase (2014) (0)
Safety and Efficacy of Hydroxychloroquine for Treatment of Non-Severe COVID-19 in Adults in Uganda: A Randomized Open Label Phase II Clinical Trial (2021) (0)
Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from Uganda (2020) (0)
Rosenthal, PJ (2007) COMPARISON OF HRP2- AND pLDH-BASED RAPID DIAGNOSTIC TESTS FOR MALARIA WITH LONGITU- (2018) (0)
Additional file 2: of Why is malaria associated with poverty? Findings from a cohort study in rural Uganda (2016) (0)
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens (2015) (0)
LLIN Evaluation in Uganda Project (LLINEUP2)—Factors associated with coverage and use of long‑lasting insecticidal nets following the 2020–21 national mass distribution campaign: a cross-sectional survey of 12 districts (2022) (0)
Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda AIDS Research and Therapy (2019) (0)
Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy (2018) (0)
Persistent malaria transmission from asymptomatic children despite highly effective malaria control in eastern Uganda (2020) (0)
The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in Nine Rural Ugandan Communities. (2022) (0)
Infant sex modifies associations between placental malaria and risk of malaria in infancy (2020) (0)
Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS,S/AS01 vaccine (2023) (0)
Management Information System Versus Enhanced Inpatient Malaria Surveillance for Estimating the Burden of Malaria Among Children (2018) (0)
Evaluation of a predictive staging model for Kaposi sarcoma in Uganda. (2015) (0)
LLIN Evaluation in Uganda Project (LLINEUP) – Effect of Long-Lasting Insecticidal Nets with and Without Piperonyl Butoxide on Malaria Indicators in Uganda 25 Months after Distribution: A Cluster-Randomised Trial (2022) (0)
Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East Africa (2022) (0)
Genetic diversity and genetic relatedness in Plasmodium falciparum parasite population in individuals with uncomplicated malaria based on microsatellite typing in Eastern and Western regions of Uganda, 2019–2020 (2021) (0)
HIV, tuberculosis, diabetes mellitus and hypertension admissions and premature mortality among adults in Uganda from 2011 to 2019: is the tide turning? (2022) (0)
Gender difference in the incidence of malaria diagnosed at public health facilities in Uganda (2022) (0)
Rapid shifts in the age-specific burden of malaria following successful control interventions in four regions of Uganda (2020) (0)
Impact of COVID-19 on routine malaria indicators in Uganda: An interrupted time series analysis (2021) (0)
254 Factors associated with development of Opportunistic Infections among patients on ART in Uganda (2009) (0)
Ten Years Outcomes in a Cohort of Patients Started on Antiretroviral Treatment in an Urban Clinic in Sub-Saharan Africa. (2014) (0)
A105 Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda (2013) (0)
Cost-effectiveness analysis of PBO-LLINs compared to Non PBO LLINs in the reduction of malaria among children in Jinja district (2020) (0)
257 Does toxicity to fixed dose stavudine, lamivudine and nevirapine regimen affect virologic suppression among HIV infected adults at the Infectious Diseases Institute, Makerere University? (2009) (0)
WITHDRAWN: Rapid decline in CD38 T cell activation in HIV infected Ugandans taking antiretroviral therapy – towards that of healthy european controls (2006) (0)
Nothing about us without us: Community-based participatory research to improve HIV care for mobile patients in Kenya and Uganda. (2022) (0)
Evaluating the epidemiology of P. falciparum parasitemia in three areas of Uganda with different transmission intensities (2016) (0)
Gravidity-dependent associations between interferon response and birth weight in placental malaria (2020) (0)
Age dependent changes in circulating Tfh cells influence the development of functional antibodies to malaria in children (2021) (0)
Title Factors associated with malaria parasitaemia , malnutrition , and anaemia among HIV-exposed and unexposed Ugandan infants : a cross-sectional survey Permalink (2013) (0)
Estimating malaria incidence from routine health facility-based surveillance data in Uganda (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Moses Robert Kamya?

Moses Robert Kamya is affiliated with the following schools:

Makerere University
University of California, San Francisco